Managers / Q1 2019
BB BIOTECH AG
CIK 0000924223 · SCHWERTSTRASSE 6, SCHAFFHAUSEN, 8200 · 411724 59 59
Reported Value
$4.0B
Q1 2019
Positions
35
Filings on Record
2
2019–present window
Filed
May 13, 2019
original filing
Summary
Bb Biotech Ag reported $4.0B in U.S.-listed holdings across 35 positions for Q1 2019.
Compared with Q4 2018, the fund opened 2 new positions and exited 1.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
Composition data arrives with ticker enrichment.
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2019
Filing History
Other Included Managers
This filing reports holdings on behalf of 4 additional managers.
- Biotech Focus N V28-11193
- Biotech Invest N V28-11191
- Biotech Target N V28-11189
- Biotech Growth N V28-11194
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.